Medical cannabis

Use of cannabis for mental health in the Canadian territories: A cross sectional study.

Schwartz N, Poon T, Hammond D, Hobin E. Substance Use and Misuse 2024; Sep 29:1-9. DOI: 10.1080/10826084.2024.2409711. Epub ahead of print.

Canada’s THC Unit: Applications for the Legal Cannabis Market.

Wood S, Gabrys R, Freeman T, Hammond D. Canada’s THC Unit: Applications for the Legal Cannabis Market. International Journal of Drug Policy 2024; 128: 104457.

Cannabidiol-only product use in Pregnancy in the United States and Canada: Findings from the International Cannabis Policy Study.

Bhatia D, Sakai J, Reddy S, Mikulich S, Hammond D. Obstetrics & Gynecology 2024; In press.

Social norms for cannabis use following non-medical legalization in Canada.

Winfield-Ward L, Hammond D. American Journal of Preventive Medicine 2023; S0749-3797(23)00513-5.

Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status.

Rup J, Freeman T, Perlman CP, Hammond D. Substance Use & Misuse 2022; 57(5):719-729.

Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.

Leung J, Chan G, Stjepanović D, Chung JYC, Hall W, Hammond D. Psychopharmacology 2022; 239(5): 1509-1519.

Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.

Rup J, Freeman T, Perlman C, Hammond D. Addictive Behaviors; 2021; 121:106991.